Ole Erik Iversen

2.6k total citations
55 papers, 2.0k citations indexed

About

Ole Erik Iversen is a scholar working on Obstetrics and Gynecology, Epidemiology and Surgery. According to data from OpenAlex, Ole Erik Iversen has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Obstetrics and Gynecology, 14 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Ole Erik Iversen's work include Cervical Cancer and HPV Research (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Ovarian cancer diagnosis and treatment (8 papers). Ole Erik Iversen is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Ovarian cancer diagnosis and treatment (8 papers). Ole Erik Iversen collaborates with scholars based in Norway, United States and United Kingdom. Ole Erik Iversen's co-authors include Lars A. Akslen, Helga B. Salvesen, Susanne Albrechtsen, Ingeborg B. Engelsen, Line Bjørge, Ian Jacobs, Andy Ryan, Nicola MacDonald, Svein Rasmussen and Lorentz M. Irgens and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Ole Erik Iversen

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Erik Iversen Norway 23 833 400 369 354 353 55 2.0k
Toru Hachisuga Japan 24 852 1.0× 675 1.7× 291 0.8× 173 0.5× 122 0.3× 125 1.8k
L.B. Twiggs United States 19 389 0.5× 345 0.9× 309 0.8× 225 0.6× 139 0.4× 40 1.4k
Su‐Cheng Huang Taiwan 25 626 0.8× 417 1.0× 293 0.8× 127 0.4× 126 0.4× 67 1.5k
Eva Chalas United States 23 525 0.6× 507 1.3× 469 1.3× 157 0.4× 89 0.3× 82 1.7k
Andrew P. Soisson United States 18 804 1.0× 336 0.8× 222 0.6× 296 0.8× 422 1.2× 50 1.4k
Yu‐Che Ou Taiwan 23 328 0.4× 267 0.7× 277 0.8× 157 0.4× 263 0.7× 108 1.4k
Giorgia Perniola Italy 30 1.1k 1.3× 1.2k 3.1× 474 1.3× 215 0.6× 107 0.3× 144 2.6k
Chiou‐Chung Yuan Taiwan 25 734 0.9× 727 1.8× 189 0.5× 154 0.4× 204 0.6× 92 1.7k
Cheryl Saenz United States 22 969 1.2× 307 0.8× 448 1.2× 360 1.0× 460 1.3× 59 1.8k
James E. Wheeler United States 27 593 0.7× 933 2.3× 392 1.1× 200 0.6× 53 0.2× 61 2.2k

Countries citing papers authored by Ole Erik Iversen

Since Specialization
Citations

This map shows the geographic impact of Ole Erik Iversen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Erik Iversen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Erik Iversen more than expected).

Fields of papers citing papers by Ole Erik Iversen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Erik Iversen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Erik Iversen. The network helps show where Ole Erik Iversen may publish in the future.

Co-authorship network of co-authors of Ole Erik Iversen

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Erik Iversen. A scholar is included among the top collaborators of Ole Erik Iversen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Erik Iversen. Ole Erik Iversen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nygård, Mari, Birgit Engesæter, Philip E. Castle, et al.. (2022). Randomized Implementation of a Primary Human Papillomavirus Testing–based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1812–1822. 15 indexed citations
2.
Moreira, Edson Duarte, Anna R. Giuliano, Jan de Hoon, et al.. (2017). Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age. Human Vaccines & Immunotherapeutics. 14(2). 396–403. 8 indexed citations
3.
Vintermyr, Olav Karsten, Ole Erik Iversen, Wim Quint, et al.. (2014). Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway. Gynecologic Oncology. 133(2). 159–166. 18 indexed citations
4.
Næss, Halvor & Ole Erik Iversen. (2013). P-piller, migrene og hjerneinfarkt. Tidsskrift for Den norske legeforening. 133(6). 621–622.
5.
Albrechtsen, Susanne, Svein Rasmussen, S Thoresen, Lorentz M. Irgens, & Ole Erik Iversen. (2008). Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ. 337(sep18 1). a1343–a1343. 133 indexed citations
6.
Iversen, Ole Erik, et al.. (2007). Medical abortion in the first trimester: The use of serum hCG and endometrial thickness as markers of completeness. The European Journal of Contraception & Reproductive Health Care. 12(4). 366–371. 15 indexed citations
7.
Iversen, Ole Erik, et al.. (2005). Response. Contraception. 73(1). 109–110. 2 indexed citations
8.
Bjørge, Line, Juha Hakulinen, OK Vintermyr, et al.. (2005). Ascitic complement system in ovarian cancer. British Journal of Cancer. 92(5). 895–905. 111 indexed citations
9.
MacDonald, Nicola, Helga B. Salvesen, Andy Ryan, et al.. (2004). Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series. International Journal of Gynecological Cancer. 14(5). 957–965. 24 indexed citations
10.
Bjørge, Line, et al.. (2001). Early pregnancy termination with mifepristone and misoprostol in Norway. Acta Obstetricia Et Gynecologica Scandinavica. 80(11). 1056–1061. 74 indexed citations
11.
Salvesen, Helga B., Nicola MacDonald, Andy Ryan, et al.. (2000). Methylation of hMLH1 in a population-based series of endometrial carcinomas.. PubMed. 6(9). 3607–13. 103 indexed citations
12.
Tandberg, Anne Helene S., Susanne Albrechtsen, & Ole Erik Iversen. (1999). Manual removal of the placenta, Incidence and clinical significance. Acta Obstetricia Et Gynecologica Scandinavica. 78(1). 33–36. 42 indexed citations
13.
Salvesen, Helga B., Ole Erik Iversen, & Lars A. Akslen. (1998). Prognostic impact of morphometric nuclear grade of endometrial carcinoma. Cancer. 83(5). 956–964. 17 indexed citations
14.
Salvesen, Helga B., Ole Erik Iversen, & Lars A. Akslen. (1998). Prognostic impact of morphometric nuclear grade of endometrial carcinoma. Cancer. 83(5). 956–964. 1 indexed citations
15.
Salvesen, Helga B., Lars A. Akslen, T Iversen, & Ole Erik Iversen. (1997). Recurrence of endometrial carcinoma and the value of routine follow up. BJOG An International Journal of Obstetrics & Gynaecology. 104(11). 1302–1307. 74 indexed citations
16.
Tegnander, Agnar, et al.. (1994). Activation of the complement system and adverse effects of biodegradable pins of poly-lactic acid (Biofix®) in osteochondritis dissecans. Acta Orthopaedica. 65(4). 472–475. 71 indexed citations
17.
Iversen, Ole Erik, et al.. (1988). DNA ploidy and steroid receptors as predictors of disease course in patients with endometrial carcinoma. Acta Obstetricia Et Gynecologica Scandinavica. 67(6). 531–537. 33 indexed citations
18.
Iversen, Ole Erik, et al.. (1986). Oral contraceptives and hepatocellular carcinoma. BMJ. 292(6536). 1668–1668. 3 indexed citations
19.
Iversen, Ole Erik, et al.. (1981). Comparison of Cytological “Jet-Wash” Specimens and Histology in Endometrial Carcinoma. Obstetrical & Gynecological Survey. 36(6). 332–332. 4 indexed citations
20.
Iversen, Ole Erik, et al.. (1980). The Isaacs cell sampler: an alternative to curettage.. BMJ. 281(6236). 364–365. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026